KALV icon

KalVista Pharmaceuticals
KALV

Overview Fund Activity

63 hedge funds and large institutions have $203M invested in KalVista Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 14 closing their positions.

Holders
63
Holders Change
-9
Holders Change %
-12.5%
% of All Funds
1.27%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
5
Increased
23
Reduced
20
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$9.62M
2
IC
2
Ikarian Capital
Texas
$15.6M
3
Russell Investments Group
3
Russell Investments Group
United Kingdom
$1.52M
4
SCM
4
Suvretta Capital Management
New York
$3.89M
5
PAMU
5
Pictet Asset Management (UK)
United Kingdom
$10.7M

Top Sellers

1
LGM
1
Logos Global Management
California
$3.78M
2
Victory Capital Management
2
Victory Capital Management
Texas
$0
3
SB
3
Samsara BioCapital
California
$1.06M
4
Norges Bank
4
Norges Bank
Norway
$269K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Nomura Asset Management
76
Nomura Asset Management
Japan
– – – –
CFGS
77
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
$0 21 +21 New
QCG
79
Quadrant Capital Group
Ohio
$0 35 +35 New
1 2 3
4